Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Moreira · SciRah

Researcher profile · Semantic Scholar

R. Moreira

Share profile

R. Moreira — researcher profile on SciRah

h-index: 11
Works: 48
Citations: 886

Most-cited papers

Comprehensive meta-analysis of key immune-related adverse events from CTLA-4 and PD-1/PD-L1 inhibitors in cancer patients
G. de Velasco, Y. Je, D. Bossé, M. Awad +7 more
2017Cancer immunology research437 citations Open access
Semantic Scholar
Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials
R. Moreira, M. Debiasi, E. Francini, P. Nuzzo +6 more
2017OncoTarget81 citations Open access
Semantic Scholar
Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
S. Yip, Connor Wells, R. Moreira, A. Wong +15 more
2018Cancer66 citations Open access
Semantic Scholar
The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.
Maxine Sun, G. de Velasco, P. Brastianos, A. Aizer +5 more
2018European Urology Focus59 citations
Semantic Scholar
Evaluation of disease‐free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial‐level meta‐analysis
L. Harshman, Wan-Ling Xie, R. Moreira, D. Bossé +3 more
2018Cancer44 citations Open access
Semantic Scholar
Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma
L. Hamieh, R. McKay, Xun Lin, R. Moreira +2 more
2017Clinical Genitourinary Cancer27 citations
Semantic Scholar
Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification
R. Moreira, R. Peixoto, Marcelo Rocha de Sousa Cruz
2015Case Reports in Oncology23 citations Open access
Semantic Scholar
Cancer Immunotherapy Principles and Practice
L. Butterfield, H. Kaufman, F. Marincola, T. Gajewski +127 more
201820 citations
Semantic Scholar
Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy
Raphael L. C. Araújo, J. M. Milani, D. Armentano, R. Moreira +3 more
2019Journal of Surgical Oncology17 citations
Semantic Scholar
The management of immune-related adverse events associated with immune checkpoint blockade
A. Fay, R. Moreira, P. Nunes, C. Albuquerque +1 more
201615 citations Open access
Semantic Scholar
Clinical activity of PD1/PDL1 inhibitors in metastatic non-clear cell renal cell carcinoma (nccRCC).
R. Moreira, R. McKay, Wan-Ling Xie, D. Heng +11 more
201712 citations
Semantic Scholar
Palliative Prognostic Index accuracy of survival prediction in an inpatient palliative care service at a Brazilian tertiary hospital
M. Fernandes, Tiago Pugliese Branco, M. Fernández, Carolina Paparelli +13 more
2021ecancermedicalscience11 citations Open access
Semantic Scholar
Real world experience of immuno-oncology agents in metastatic renal cell carcinoma: Results from the IMDC.
S. Yip, Connor Wells, R. Moreira, A. Wong +16 more
201711 citations
Semantic Scholar
Outcomes of PD-1/PD-L1 responders who discontinue therapy for immune-related adverse events (irAEs): Results of a cohort of patients (pts) with metastatic renal cell carcinoma (mRCC).
R. McKay, D. Martini, R. Moreira, L. Hamieh +8 more
20179 citations
Semantic Scholar
Impact of immune checkpoint protein expression in tumor cells and tumor infiltrating CD8+ T cells on clinical benefit from PD-1 blockade in metastatic clear cell renal cell carcinoma (mccRCC).
Jean-Christophe Pignon, Opeyemi A. Jegede, K. Mahoney, R. Moreira +12 more
20178 citations
Semantic Scholar
Differential Side Effects Profile in mCRPC Patients Treated With Abiraterone or Enzalutamide: A Meta-Analysis of Randomized Controlled Trials.
R. Moreira, M. Debiasi, F. Maluf, J. Bellmunt +3 more
2016Clinical advances in hematology & oncology : H&O8 citations
Semantic Scholar
Mutation profile in non-small cell lung cancer: Analysis of a Brazilian population.
J. R. Gomes, M. Amarante, R. D'Alpino, R. Moreira +9 more
20156 citations
Semantic Scholar
Next-generation sequencing (NGS) in metastatic breast cancer (mBC) patients: Translation from sequence data into clinical practice.
R. Moreira, R. Peixoto, Tercia Tarciane Soares de Sousa, M. Cruz +2 more
2015Journal of Clinical Oncology5 citations
Semantic Scholar
Body mass index and immune checkpoint inhibitor efficacy in metastatic cancer patients: A Brazilian retrospective study
R. Moreira, M. Fernandes, M. Monteiro, F. Luiz +10 more
2022Frontiers in Urology4 citations Open access
Semantic Scholar
Impact of Aspirin and Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs on Outcomes in Patients with Metastatic Renal Cell Carcinoma
L. Hamieh, R. Moreira, Xun Lin, R. Simantov +2 more
20184 citations Open access
Semantic Scholar
Fourth-line targeted therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
I. Stukalin, Connor Wells, A. Fraccon, F. Pasini +16 more
20174 citations
Semantic Scholar
Meta-analysis of disease free survival (DFS) as a surrogate for overall survival (OS) in localized renal cell carcinoma (RCC).
L. Harshman, Wan-Ling Xie, R. Moreira, Ruiz Gustavo +2 more
20173 citations
Semantic Scholar
Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab.
R. Moreira, L. Hamieh, E. Gjini, Ana Lako +3 more
2017Journal for ImmunoTherapy of Cancer2 citations Open access
Semantic Scholar
Regression of multifocoal in transit melanoma metastases after palliative resection of dominant masses and 2 years after treatment with ipilimumab
R. Moreira, L. Hamieh, E. Gjini, Ana Lako +3 more
2017Journal of Immunotherapy for Cancer2 citations Open access
Semantic Scholar
Next-generation sequencing (NGS) in metastatic gastrointestinal cancer (mGIC) patients: Translation from sequence data into clinical practice.
R. Moreira, M. Alessandretti, C. Abrahao, Aline Da Rocha Lino +11 more
20152 citations
Semantic Scholar
Evaluation of disease-free survival as an intermediate metric for overall survival in localized renal cell carcinoma: A trial-level meta-analysis.
L. Harshman, Wan-Ling Xie, R. Moreira, D. Bossé +3 more
20171 citations
Semantic Scholar
Is neoadjuvant chemotherapy beneficial before radical cystectomy? Examining the external validity of the SWOG-8710 trial
N. Hanna, Q. Trinh, J. Sammon, T. Seisen +8 more
20171 citations
Semantic Scholar
Abstract A18: Genomic and neoantigen evolution and resistance to immune checkpoint blockade in metastatic renal cell carcinoma
Diana Miao, G. de Velasco, D. Adeegbe, Craig K. Norton +7 more
20171 citations
Semantic Scholar
Induction FOLFIRINOX followed by chemoradiation with capecitabine for unresectable locally advanced pancreatic cancer (LAPC): Preliminary data.
Rafaela Kássia Ferreira de Carvalho, E. Gil, R. Moreira, R. Peixoto +7 more
20151 citations
Semantic Scholar
Role of second-line gemcitabine after FOLFIRINOX failure in advanced pancreatic adenocarcinoma: A retrospective analysis.
Aline Da Rocha Lino, R. M. Martins, C. Abrahao, R. Moreira +13 more
20151 citations
Semantic Scholar
Treatment of a Pineoblastoma in a 51-year-old patient
Carina Meira Abrahão, M. Alessandretti, R. Moreira, A. Buzaid +1 more
20141 citations Open access
Semantic Scholar
Oncological outcomes of extended versus standard pelvic lymph node dissection in radical cystectomy: An updated systematic review and meta‐analysis
Rafael Matos Vieira Gordilho, N. C. L. Barretto, R. Silvão, Felipe Pereira Garrido Pazos +16 more
2026BJUI Compass0 citations Open access
Semantic Scholar
Association of body mass index (BMI) with clinical efficacy of immune checkpoint inhibitors (ICI) in advanced cancer patients: A retrospective analysis.
R. Moreira, M. Fernandes, M. Monteiro, F. Luiz +9 more
20200 citations
Semantic Scholar
EP1.15-25 A Rare Case of Metastatic Leiomyoma of the Lung
F. Luiz, A. Abrahao, E. Silva, C. Bognar +3 more
2019Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
P1.09-04 Comprehensive Genomic Profiling in a Brazilian Cohort of Lung Cancer Patients: Real-World Impact
T. Padua, M. Monteiro, M. Silvino, L. Carvalho +9 more
2019Journal of Thoracic Oncology0 citations Open access
Semantic Scholar
Distance from the anal verge as an indirect measure to predict response to anti-EGFR therapy in left side metastatic colon cancer.
D. Armentano, M. Monteiro, R. Araujo, R. Arakelian +4 more
2019Journal of Clinical Oncology0 citations
Semantic Scholar
Next-generation sequencing (NGS) for personalized therapy in metastatic breast cancer: Selection of therapy and outcomes.
J. R. Gomes, R. Moreira, M. Alessandretti, Marcelo Rocha de Sousa Cruz
20170 citations
Semantic Scholar
Is neoadjuvant chemotherapy beneficial before radical cystectomy? Examining the external validity of the SWOG-8710 trial.
N. Hanna, Q. Trinh, J. Sammon, T. Seisen +8 more
20170 citations
Semantic Scholar
Contemporary incidence and epidemiologic trends of brain metastases at renal cell carcinoma diagnosis.
Maxine Sun, G. de Velasco, P. Brastianos, R. Moreira +3 more
20170 citations
Semantic Scholar
Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
S. Yip, Connor Wells, R. Moreira, A. Wong +15 more
20170 citations
Semantic Scholar
The Brazilian experience with biochemotherapy for metastatic melanoma: Long-term results in 163 patients.
R. Moreira, R. D'Alpino, Tercia Tarciane Soares de Sousa, Aline Da Rocha Lino +6 more
20150 citations
Semantic Scholar
Impact of first-line fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with advanced gastroesophageal adenocarcinoma: A retrospective analysis.
Aline Da Rocha Lino, R. Moreira, J. R. Gomes, Tarcia Tarciane Soares de Sousa +11 more
20150 citations
Semantic Scholar
Next-generation sequencing in metastatic lung cancer patients: Translation from sequence data into clinical practice.
J. R. Gomes, R. Moreira, R. D'Alpino, M. Cruz +8 more
20150 citations
Semantic Scholar
Next-generation sequencing (NGS) in advanced pancreatic adenocarcinoma (PA): A Brazilian experience.
R. Moreira, M. Alessandretti, Aline Da Rocha Lino, R. M. Martins +9 more
20150 citations
Semantic Scholar
Impact of comprehensive tumor profiling using a targeted next-generation sequencing panel in Brazil.
R. Moreira, M. Cruz, J. R. Gomes, Tercia Tarciane Soares de Sousa +8 more
20150 citations
Semantic Scholar
Palliative intra-arterial high-dose cisplatin for inoperable sarcoma.
M. Amarante, J. R. Gomes, C. Kawamura, R. Schmerling +6 more
20150 citations
Semantic Scholar
Abstract P3-13-09: Personalized therapy in breast cancer: Brazilian experience
R. Moreira, M. Alessandretti, A. Buzaid, M. Cruz
20150 citations
Semantic Scholar
Brain metastasis are more frequent in EGFR mutated than in wild-type lung adenocarcinoma.
M. Amarante, R. D'Alpino, J. R. Gomes, R. Moreira +6 more
20150 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Choueiri×18
Invite
T. Choueiri — researcher profile on SciRah
F. Maluf×14
Invite
F. Maluf — researcher profile on SciRah
A. Buzaid×14
Invite
A. Buzaid — researcher profile on SciRah
M. Cruz×12
Invite
M. Cruz — researcher profile on SciRah

×11

Invite

J. R. Gomes — researcher profile on SciRah

M. Amarante×11

Invite

M. Amarante — researcher profile on SciRah

Invite

F. Schutz — researcher profile on SciRah

Invite

R. Peixoto — researcher profile on SciRah

Tercia Tarciane Soares de Sousa×7

Invite

Tercia Tarciane Soares de Sousa — researcher profile on SciRah

R. Schmerling×7

Invite

R. Schmerling — researcher profile on SciRah

M. Alessandretti×7

Invite

M. Alessandretti — researcher profile on SciRah

Invite

R. D'Alpino — researcher profile on SciRah